71 related articles for article (PubMed ID: 361438)
1. Chemical characterization of products of activated lymphocytes.
Sorg C; Klinkert W
Fed Proc; 1978 Nov; 37(13):2748-53. PubMed ID: 361438
[No Abstract] [Full Text] [Related]
2. A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity.
Rouveix B; Badenoch-Jones P; Turk JL
Immunology; 1979 Mar; 36(3):589-94. PubMed ID: 374256
[TBL] [Abstract][Full Text] [Related]
3. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
4. [Chemical mediator, lymphokine, produced by activated lymphocytes].
Morisawa S
Nihon Rinsho; 1978; 36(5):937-43. PubMed ID: 353329
[No Abstract] [Full Text] [Related]
5. Spontaneous MIF secretion by peripheral lymphocytes of cancer patients.
Waldman RH; Ganguly R; Cusumano CL
J Reticuloendothel Soc; 1978 May; 23(5):335-41. PubMed ID: 353280
[No Abstract] [Full Text] [Related]
6. Studies on experimental pulmonary granulomas. I. Detection of lymphokines in granulomatous lesions.
Masih N; Majeska J; Yoshida T
Am J Pathol; 1979 May; 95(2):391-406. PubMed ID: 377991
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
[TBL] [Abstract][Full Text] [Related]
8. [Isolation and testing of factors affecting macrophage and leukocyte migration].
Gankovskaia LV; Gvozdeva NA; Moskvina SN
Lab Delo; 1986; (10):612-4. PubMed ID: 2432322
[No Abstract] [Full Text] [Related]
9. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
Ruthlomnitzer ; Rabson AR; Koornhof HJ
Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
[TBL] [Abstract][Full Text] [Related]
10. [Detection of the macrophage migration inhibitory factor as a possible measure of sensitization to seminal antigens (author's transl)].
Mettler L; Scheidel P
Geburtshilfe Frauenheilkd; 1974 Mar; 34(3):157-63. PubMed ID: 4600994
[No Abstract] [Full Text] [Related]
11. Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
Górski AJ; Dupont B; Hansen JA; O'Reilly R; Smithwick E; Górska R; Good RA
Clin Exp Immunol; 1976 Dec; 26(3):505-10. PubMed ID: 795576
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory, non-antibody lymphocytic mediators (lymphokines).
Bendtzen K; Bendixen G
Allerg Immunol (Leipz); 1980; 26(4):293-309. PubMed ID: 6163346
[TBL] [Abstract][Full Text] [Related]
13. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
Center DM; Cruikshank WW; Berman JS; Beer DJ
J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mediators in culture filtrates of Escherichia coli.
Yoshida T; Cohen S; Bigazzi PE; Kurasuji T; Amsden A
Am J Pathol; 1975 Nov; 81(2):389-400. PubMed ID: 1103632
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
17. Production of MIF-like supernatants by rheumatoid arthritis lymphocytes stimulated by immunoglobulin G.
Sany J; Mathieu O; Clot J; Mandin J; Serre H
Rheumatology; 1975; 6():131-8. PubMed ID: 1105742
[TBL] [Abstract][Full Text] [Related]
18. [Systemic cellular mediated immunity in children hospitalized with clinical, virological and serological diagnosis of Coxsackie B virosis].
Voiculescu C; Stanciu L; Nedelcu C; Rogoz S; Dimitriu I; Tăţulescu M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1981; 26(4):235-41. PubMed ID: 6276961
[No Abstract] [Full Text] [Related]
19. Production and partial characterization of dog macrophage migration inhibitory factor.
Schnizlein CT; Bice DE
J Reticuloendothel Soc; 1980 Apr; 27(4):393-400. PubMed ID: 6989994
[No Abstract] [Full Text] [Related]
20. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
